Group Patient Age/Sex Underlying disease ACEi/ARB Treatment (days) O2 therapy Incubation period (days)
Severe group (O2 inhalation needed) A 79/F DM None Lopinavir/ritonavir (8) MV 1
B 79/M HTN/DM None Lopinavir/ritonavir (10) MV 9
C 75/F HTN/CVA None Lopinavir/ritonavir (10) NP 1
D 61/F None None Lopinavir/ritonavir (11) HF + NP 8
Mild group (O2 inhalation not needed) E 46/M HTN/Dyslipidemia None None None -2‡
F 30/M HTN Azilsartan None None 1
G 30/M None None None None 0
H 29/F None None None None 1
I 74/M HTN/DM Perindopril Lopinavir/ritonavir (8) None 7
J 36/M None None Hydroxychloroquine (5) None -1